Security
ABT · Abbott Laboratories
40 institutional holder(s) · 40 congressional trade(s)
Abbott Laboratories makes medical devices (FreeStyle Libre glucose monitors), diagnostics, nutrition products (Ensure, Similac), and branded generic drugs. It is held by 13 of 26 tracked funds in the latest quarter and traded by 29 members of Congress in disclosed filings.
Institutional holders
13F
| Fund | Value | Shares |
|---|
| Vanguard Group |
$19.85B | 158,392,863 |
| State Street |
$8.17B | 79,575,468 |
| BlackRock |
$5.81B | 56,562,342 |
| Vanguard Group |
$3.89B | 18,219,122 |
| BlackRock |
$3.73B | 36,284,746 |
| Geode Capital Management |
$3.42B | 33,531,277 |
| Fidelity |
$3.35B | 13,414,459 |
| State Street |
$1.93B | 7,740,942 |
| BlackRock |
$1.46B | 14,194,408 |
| BlackRock |
$1.28B | 5,135,439 |
| Vanguard Group |
$1.22B | 9,715,723 |
| Geode Capital Management |
$997.7M | 4,009,644 |
| Morgan Stanley |
$978.8M | 9,533,531 |
| BlackRock |
$863.8M | 3,456,479 |
| Morgan Stanley |
$859.5M | 8,371,770 |
| Fidelity |
$827.5M | 3,311,217 |
| Two Sigma Investments |
$655.9M | 6,388,828 |
| Bank of America |
$646.2M | 6,293,738 |
| Bank of America |
$599.1M | 5,835,285 |
| Geode Capital Management |
$576.8M | 5,617,518 |
| Fidelity |
$518.6M | 5,050,885 |
| BlackRock |
$499.8M | 4,868,309 |
| BlackRock |
$492.8M | 4,799,630 |
| BlackRock |
$484M | 4,714,338 |
| Vanguard Group |
$474.4M | 3,786,042 |
| Fidelity |
$458.9M | 1,836,304 |
| BlackRock |
$434.8M | 1,739,716 |
| Bank of America |
$433.3M | 4,220,166 |
| Fidelity |
$419.7M | 4,087,891 |
| BlackRock |
$416.7M | 4,059,079 |
| BlackRock |
$377.4M | 3,675,852 |
| BlackRock |
$356.3M | 3,470,551 |
| Vanguard Group |
$352.4M | 2,812,659 |
| BlackRock |
$295.1M | 2,874,128 |
| BlackRock |
$281.4M | 2,740,384 |
| BlackRock |
$278.1M | 2,708,928 |
| Morgan Stanley |
$253.9M | 2,472,762 |
| Morgan Stanley |
$243.6M | 2,372,918 |
| Fidelity |
$238.2M | 952,997 |
| Morgan Stanley |
$230.9M | 2,248,633 |
Congressional trades
STOCK Act